Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Austco Healthcare Limited ( (AU:AHC) ) just unveiled an update.
Austco Healthcare Limited reported record revenues of $81.4 million for the fiscal year ending June 30, 2025, marking a 40% increase from the previous year. This growth was driven by both organic expansion and strategic acquisitions, with EBITDA rising by 62% to $13.0 million. The company has successfully integrated acquisitions like Teknocorp, Amentco, and G&S Technologies, which have expanded its capabilities and customer reach. Looking ahead, Austco plans to continue integrating new acquisitions, improve operating leverage, and sustain innovation through R&D investment, positioning itself for sustained growth in the healthcare communication and workflow solutions market.
The most recent analyst rating on (AU:AHC) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Austco Healthcare Limited stock, see the AU:AHC Stock Forecast page.
More about Austco Healthcare Limited
Austco Healthcare Limited operates in the healthcare industry, specializing in communication and workflow solutions. The company focuses on innovation and strategic acquisitions to enhance its capabilities and customer propositions, with a significant market presence in Australia, New Zealand, and internationally.
Average Trading Volume: 268,031
Technical Sentiment Signal: Buy
Current Market Cap: A$134.3M
For a thorough assessment of AHC stock, go to TipRanks’ Stock Analysis page.